基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 6,452.81
成立日期: 26/01/2004
 
分析
市值分佈:
96.57%
大市值
2.18%
中市值
0.62%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 410  
0%
 
100%
     10大 (51.75%)
代號 名稱 佔比% ▼ 持有日期
WVEWave Life Sciences Inc0.0130/09/2026
ACRSAclaris Therapeutics0.0130/09/2026
SVRASavara0.0130/09/2026
OLMAOlema Oncology Inc0.0130/09/2026
TLRYTilray Brands Inc.0.0130/09/2026
CTMXCytomX Therapeutics0.0130/09/2026
CERSCerus Corp0.0130/09/2026
ALTAltimmune0.0130/09/2026
CAPRCapricor Therapeutics0.0130/09/2026
ALMSAlumis Inc.0.0130/09/2026
VSTMVerastem0.0130/09/2026
STLNStarling Oncology, Inc.0.0130/09/2026
ARVNArvinas0.0130/09/2026
VORVor Biopharma Inc0.0130/09/2026
FLGTFulgent Genetics0.0130/09/2026
ALLOAllogene Therapeutics0.0130/09/2026
CCRN--0.0130/06/2026
RGNXREGENXBIO0.0130/09/2026
LXRXLexicon Pharmaceuticals0.0130/09/2026
OABIOmniAb0.0130/09/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16   17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.